Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
This podcast was originally published by CancerCare on June 20, 2019, here.
Listen Now
Topics Covered
- Review of CLL
- Significant Role of Testing in Informing Your Treatment Choices
- First Line Treatment Options
- Treatment of Relapsed/Refractory CLL
- Importance of Re-Testing in Determining Treatment for 2nd and 3rd Line Treatments
- Current Perspectives on New & Emerging Treatments for CLL
- Key Questions to Ask & Re-Ask Your Health Care Team
- Practical & Psychosocial Support to Cope with CLL
- Questions for Our Panel of Experts
Our Panel of Experts
Alexey V. Danilov, MD, PhD
Associate Professor of Medicine, Knight Cancer Institute, Oregon Health & Science University (OHSU)
Lindsey E. Roeker, MD
Hematology/Medical Oncology Fellow, Department of Medicine, Memorial Sloan Kettering Cancer Center
Patricia Koffman
Co-Founder and Executive Director, CLL Society Inc.
Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Director of Education and Training, CancerCare
